Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain.

Publication

Citation
Shao PP, Ye F, Chakravarty PK, Varughese DJ, Herrington JB, Dai G, Bugianesi RM, Haedo RJ, Swensen AM, Warren VA, Smith MM, Garcia ML, McManus OB, Lyons KA, Li X, Green M, Jochnowitz N, McGowan E, Mistry S, Sun SY, Abbadie C, Kaczorowski GJ, Duffy JL.: Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain. J Med Chem, Volume 55 (22), 2012
Authors
Shao PP, Ye F, Abbadie C, Bugianesi RM, Chakravarty PK, Dai G, Duffy JL., Garcia ML, Green M, Haedo RJ, Herrington JB, Jochnowitz N, Kaczorowski GJ, Li X, Lyons KA, McGowan E, McManus OB, Mistry S, Smith MM, Sun SY, Swensen AM, Varughese DJ, Warren VA
Journal
J Med Chem
Year
2012
PubMed
23098566
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc